Pugoy, Manilyn .

HRN: 25-07-89  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/24/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/24/2024
05/26/2024
IV
Q8 6 Doses
Q8
Sp Pelvic Lap
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Intra-abdominalCentral Nervous System    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: